✦ LIBER ✦

Features and Risk Factors of Peripheral Neuropathy During Treatment with Bortezomib for Advanced Multiple Myeloma

✍ Scribed by El-Cheikh, Jean; Stoppa, Anne-Marie; Bouabdallah, Réda; de Lavallade, Hugues; Coso, Diane; de Collela, Jean-Marc Schiano; Auran-Schleinitz, Thérèse; Gastaut, Jean-Albert; Blaise, Didier; Mohty, Mohamad

Book ID: 119936021
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 119 KB
Volume: 8
Category: Article
ISSN: 1557-9190
DOI: 10.3816/clm.2008.n.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for, and reversibility of,

Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib–melphalan–prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study

✍ Meletios A. Dimopoulos; Maria-Victoria Mateos; Paul G. Richardson; Rudolf Schlag 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

176: Phase I/II Trial of Bortezomib Main

176: Phase I/II Trial of Bortezomib Maintenance following Autologous Peripheral Blood Progenitor Cell Transplantation as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma

✍ G.J. Schiller; M. Liao; J.P. Sohn; R. Malone; K. Bartoni; B. Habtemariam; R. Paq 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB

153: Phase I/II trial of bortezomib main

153: Phase I/II trial of bortezomib maintenance following autologous peripheral blood progenitor cell transplantation as treatment for intermediate- and advanced-stage multiple myeloma

✍ G.J. Schiller; J.P. Sohn; P. Malone; K. Bartoni; B. Habtemariam; P. Paquette; S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB

P1176 INCIDENCE AND RISK FACTORS FOR INF

P1176 INCIDENCE AND RISK FACTORS FOR INFECTIONS DURING INTERFERON-BASED TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH ADVANCED HEPATIC FIBROSIS

✍ Maan, R.; van der Meer, A.J.; Hansen, B.E.; Feld, J.J.; Wedemeyer, H.; Dufour, J 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 54 KB